ChemWiki

username password

Vicinal Syn Dihydroxylation

    Osmium tetroxide oxidizes alkenes to give glycols through syn addition. A glycol, also known as a vicinal diol, is a compound with two -OH groups on adjacent carbons. 

    glycol.bmp

    Introduction

    The reaction with OsO4 is a concerted process that has a cyclic intermediate and no rearrangements. Vicinal syn dihydroxylation complements the epoxide-hydrolysis sequence which constitutes an anti dihydroxylation of an alkene (section 12-10). When an alkene reacts with osmium tetroxide, stereocenters can form in the glycol product. Cis alkenes give meso products and trans alkenes give racemic mixtures.

    Cis alkenes.bmp

    OsO4  is prepared by the reaction of Os + 2O2. Since Osmium tetroxide is expensive and highly toxic, the reaction with alkenes has been modified. Catalytic amounts of OsO4 and stoichiometric amounts of an oxidizing agent such as hydrogen peroxide are now used to eliminate some hazards. Also, an older reagent that was used instead of OsO4 was potassium permanganate, KMnO4. Although syn diols will result from the reaction of KMnO4 and an alkene, potassium permanganate is less useful since it gives poor yields of the product because of overoxidation. 

    Mechanism

    • Electrophilic attack on the alkene
      • Pi bond of the alkene acts as the nucleophile and reacts with osmium (VIII) tetroxide (OsO4
      • 2 electrons from the double bond flows toward the osmium metal
        • In the process, 3 electron pairs move simultaneously
      • Cyclic ester with Os (VI) is produced
    • Reduction
      • H2S reduces the cyclic ester
        • NaHSO4 with H2O may be used 
      • Forms the syn-1,2-diol (glycol)

    Example: Dihydroxylation of 1-ethyl-1-cycloheptene

    example.bmp

    Chemical Highlight

    Antitumor drugs have been formed by using dihydroxylation. This method has been applied to the enantioselective synthesis of ovalicin, which is a class of fungal-derived products called antiangiogenesis agents. These antitumor products can cut off the blood supply to solid tumors. A derivative of ovalicin, TNP-470, is chemically stable, nontoxic, and noninflammatory. TNP-470 has been used in research to determine its effectiveness in treating cancer of the breast, brain, cervix, liver, and prostate.

    References

    1. Dehestani, Ahmad et al. (2005). Ligand-assisted reduction of osmium tetroxide with molecular hydrogen via a [3+2] mechanism. Journal     of the American Chemical Society, 2005, 127 (10), 3423-3432.
    2. Sorrell, Thomas, N. Organic Chemistry. New York: University Science Books, 2006.
    3. Vollhardt, Peter, and Neil E. Schore. Organic Chemistry: Structure and Function. 5th Edition. New York: W. H. Freeman & Company, 2007.

    Problems

    Questions:

    1. Give the major product.

    Problem 1 (1).bmp

    2. What is the product in the dihydroxylation of (Z)-3-hexene?

     Problem 2.bmp

    3. What is the product in the dihydroxylation of (E)-3-hexene?

    Problem 3.bmp

    4. Draw the intermediate of this reaction.

    Problem 4.bmp

    5. Fill in the missing reactants, reagents, and product.

    Problem 5.bmp

     

    Answers:

    1. A syn-1,2-ethanediol is formed. There is no stereocenter in this particular reaction. The OH groups are on the same side.

    Answer 1.bmp

    2. Meso-3,4-hexanediol is formed. There are 2 stereocenters in this reaction.

    Answer 2.bmp

    3. A racemic mixture of 3,4-hexanediol is formed. There are 2 stereocenters in both products.

    Answer 3.bmp

    4. A cyclic osmic ester is formed.

    Answer 4.bmp

    5. The Diels-Alder cycloaddition reaction is needed in the first box to form the cyclohexene. The second box needs a reagent to reduce the intermediate cyclic ester (not shown). The third box has the product: 1,2-cyclohexanediol.

    Answer 5.bmp

    Contributors

    • Shivam Nand

    This page viewed 13363 times
    The ChemWiki has 9247 Modules.

     

    Creative Commons 
License    UC Davis ChemWiki by University of California, Davis is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 United States License
    Permissions beyond the scope of this license may be available at copyright@ucdavis.edu. Terms of Use
    Powered by Mindtouch Core 2010

    You must login to post a comment.
    FileSizeDateAttached by 
     Answer 1 (1).skc
    No description
    888 bytes21:31, 16 Mar 2009Shivam NandActions
     Answer 1.bmp
    No description
    23.68 kB00:40, 28 Feb 2009Shivam NandActions
     Answer 2 (1).skc
    No description
    1159 bytes21:31, 16 Mar 2009Shivam NandActions
    Answer 2.bmp
    No description
    55.32 kB00:43, 28 Feb 2009Shivam NandActions
     Answer 3 (1).skc
    No description
    2.18 kB21:31, 16 Mar 2009Shivam NandActions
    Answer 3.bmp
    No description
    462.77 kB00:48, 28 Feb 2009Shivam NandActions
    Answer 4.bmp
    No description
    98.74 kB14:42, 1 Mar 2009Shivam NandActions
     Answer 4.skc
    No description
    1558 bytes21:31, 16 Mar 2009Shivam NandActions
    Answer 5.bmp
    No description
    182.06 kB01:13, 1 Mar 2009Shivam NandActions
     Answer 5.skc
    No description
    1878 bytes21:31, 16 Mar 2009Shivam NandActions
    Cis alkenes.bmp
    No description
    482.54 kB21:49, 16 Mar 2009Shivam NandActions
    Cis alkenes.skc
    No description
    6.98 kB21:49, 16 Mar 2009Shivam NandActions
     Dihydroxylation (1).bmp
    No description
    343.59 kB20:47, 8 Feb 2009Shivam NandActions
    example (1).skc
    No description
    4.51 kB21:39, 16 Mar 2009Shivam NandActions
     example.bmp
    No description
    550.27 kB21:39, 16 Mar 2009Shivam NandActions
     glycol.bmp
    No description
    24.8 kB21:03, 16 Mar 2009Shivam NandActions
     glycol.mol
    No description
    806 bytes21:31, 16 Mar 2009Shivam NandActions
    Problem 1 (1).bmp
    No description
    26.15 kB00:24, 28 Feb 2009Shivam NandActions
     Problem 1 (1).skc
    No description
    505 bytes21:32, 16 Mar 2009Shivam NandActions
     Problem 2 (1).skc
    No description
    665 bytes21:33, 16 Mar 2009Shivam NandActions
    Problem 2.bmp
    No description
    57.21 kB00:34, 28 Feb 2009Shivam NandActions
     Problem 3 (1).skc
    No description
    881 bytes21:33, 16 Mar 2009Shivam NandActions
    Problem 3.bmp
    No description
    177.68 kB00:37, 28 Feb 2009Shivam NandActions
     Problem 4.bmp
    No description
    123.59 kB00:55, 1 Mar 2009Shivam NandActions
     Problem 4.skc
    No description
    1232 bytes21:33, 16 Mar 2009Shivam NandActions
     Problem 5.bmp
    No description
    185.68 kB00:55, 1 Mar 2009Shivam NandActions
     Problem 5.skc
    No description
    805 bytes21:33, 16 Mar 2009Shivam NandActions